$INDI

Wu Naixi sold $34K of INDI

Wu Naixi (Chief Financial Officer) sold 6,652 shares of indie Semiconductor, Inc. (INDI) at $5.12 on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wu Naixi
Published Jun 3, 2026, 10:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 10:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$INDI
Neutral
medium confidence
Mentioned
$INDI
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INDINeutralLow
01

Why it matters

Because the sale is pre-arranged, it is generally treated as routine compliance rather than a fresh fundamental update; traders may still monitor for clustering of insider sales or changes in plan behavior.

02

Market read

A single 10b5-1 insider sale is unlikely to drive a sustained repricing without accompanying operational/financial catalysts.

03

What to watch

The article does not state total planned sale size, timing windows, or whether other insiders are buying/selling concurrently, which limits inference from a single transaction.

Relevance 6/10Novelty 4/10Timing: SEC Form 4 filed today; sale occurred 2026-06-02

Background

The filing is an SEC Form 4 insider transaction: CFO Wu Naixi sold shares at $5.1169/share under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$INDINeutralMedium confidence
Context

Indie Semiconductor CFO Wu Naixi sold 6,652 shares in an open-market transaction disclosed on SEC Form 4.

Expected impact

Likely limited/short-lived impact; any reaction should fade unless followed by additional insider activity or fundamental news.

Evidence & confidence

The filing is an ownership-change disclosure (Form 4) with an explicitly pre-arranged 10b5-1 plan, reducing interpretability as a new bearish signal.

Market effects

No direct sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling over time can coincide with management’s view of near-term valuation or liquidity needs—watch for follow-on filings.

Key entities

  • indie Semiconductor, Inc.

    Company whose CFO insider sale is disclosed on SEC Form 4.

  • Wu Naixi

    Chief Financial Officer who sold 6,652 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KRMNMed

OC Aerospace, Tech Companies Report Booming Sales

Karman Holdings (NYSE: KRMN) raised its FY2026 revenue outlook to $730M-$745M after Q2 revenue rose 58% to $182M, beating expectations. The article also summarizes earnings for TTM Technologies (TTMI), Viant Technology (DSP), Ducommun (DCO), Indie Semiconductor (INDI), and Clean Energy Fuels (CLNE), citing revenue and guidance figures.

$INDIMedAI 8/10

Indie Semi Jumps on Revenue Increase

Indie Semiconductor (Nasdaq: INDI) shares rose 16% to $4.00 in after-hours after reporting 24% higher Q2 revenue versus the same period in 2025. For the current quarter, it expects revenue of $67 million to $73 million, implying about 30% YoY growth at the midpoint.

$INDIHigh

indie Semiconductor, Inc. (INDI): Results of Operations and Financial Condition

indie Semiconductor, Inc. (INDI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 indie Reports Second Quarter 2026 Results • Delivers Revenue of $64M, up 24% Y-o-Y and exceeds midpoint of the guidance range • Guides for accelerating growth of 30% Y-o-Y in Q3 2026 • Substantially narrows GAAP and Non-GAAP Operating Losses • Gains global OEM adopti

$HIVEMedAI 8/10

Investors’ Stock Portfolio: Top 10 Penny Stocks To Buy

The article says US small-cap and penny stocks are benefiting from AI-driven risk appetite, citing the Russell 2000’s 16% YTD outperformance. It lists “Top 10” penny stocks under $5, using S&P 500 10% YTD outperformance, >20% upside, and hedge-fund holdings. For HIVE (share $4.54), it reports FY2026 revenue $297.8M (+158%) and adjusted EBITDA $72.9M. For indie Semiconductor (share $4.93), Benchmark reiterates Buy and an $8 target after a €40M acquisition of ams OSRAM’s CMOS image sensor business